473 related articles for article (PubMed ID: 12086958)
1. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways.
Begum N; Sandu OA; Duddy N
Diabetes; 2002 Jul; 51(7):2256-63. PubMed ID: 12086958
[TBL] [Abstract][Full Text] [Related]
2. Selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle.
Sandu OA; Ito M; Begum N
J Appl Physiol (1985); 2001 Sep; 91(3):1475-82. PubMed ID: 11509551
[TBL] [Abstract][Full Text] [Related]
3. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways.
Begum N; Duddy N; Sandu O; Reinzie J; Ragolia L
Mol Endocrinol; 2000 Sep; 14(9):1365-76. PubMed ID: 10976915
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.
Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Smolenski A; Lohmann SM; Bertoglio J; Chardin P; Pacaud P; Loirand G
J Biol Chem; 2000 Jul; 275(28):21722-9. PubMed ID: 10783386
[TBL] [Abstract][Full Text] [Related]
5. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation.
Sandu OA; Ragolia L; Begum N
Diabetes; 2000 Dec; 49(12):2178-89. PubMed ID: 11118023
[TBL] [Abstract][Full Text] [Related]
6. Active Rho kinase (ROK-alpha ) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells.
Begum N; Sandu OA; Ito M; Lohmann SM; Smolenski A
J Biol Chem; 2002 Feb; 277(8):6214-22. PubMed ID: 11739394
[TBL] [Abstract][Full Text] [Related]
7. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
8. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T
Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction.
Takizawa S; Ozaki H; Karaki H
Eur J Pharmacol; 1997 Jul; 330(2-3):143-50. PubMed ID: 9253947
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.
Satpathy M; Gallagher P; Lizotte-Waniewski M; Srinivas SP
Exp Eye Res; 2004 Oct; 79(4):477-86. PubMed ID: 15381032
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
[TBL] [Abstract][Full Text] [Related]
12. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.
Pang H; Guo Z; Su W; Xie Z; Eto M; Gong MC
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C352-60. PubMed ID: 15814590
[TBL] [Abstract][Full Text] [Related]
13. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Vaillant N; Gadeau AP; Desgranges C; Scalbert E; Chardin P; Pacaud P; Loirand G
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1751-61. PubMed ID: 10843869
[TBL] [Abstract][Full Text] [Related]
14. Insulin signaling in the vasculature.
Begum N
Front Biosci; 2003 Sep; 8():s796-804. PubMed ID: 12957877
[TBL] [Abstract][Full Text] [Related]
15. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling.
Chitaley K; Webb RC
Hypertension; 2002 Feb; 39(2 Pt 2):438-42. PubMed ID: 11882586
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology.
Brown C; Pan X; Hassid A
Circ Res; 1999 Apr; 84(6):655-67. PubMed ID: 10189353
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance.
Boer C; van Nieuw Amerongen GP; Groeneveld AB; Scheffer GJ; de Lange JJ; Westerhof N; van Hinsbergh VW; Sipkema P
Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L649-55. PubMed ID: 14514519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
